Trimethoprim-sulfamethoxazole as toxoplasmosis prophylaxis for heart transplant recipients [1] (multiple letters)

Clinical Infectious Diseases

Volumn 36, Issue 7, 2003, Pages 932-933

  Muñoz, Patricia ^a   Arencibia, Jorge ^b   Rodríguez, Claudia ^a   Rivera, Marisa ^a   Palomo, Jesús ^a   Yañez, Juan ^a   Bouza, Emilio ^a   Montoya, Jose G ^c,e   Remington, Jack S ^d  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^b HOSPITAL UNIVERSITARIO DE GRAN CANARIA DR NEGRÍN   (Spain)

^c PALO ALTO MEDICAL FOUNDATION   (United States)

^d STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e Research Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COTRIMOXAZOLE; IMMUNOGLOBULIN G; PYRIMETHAMINE; SULFADIAZINE;

CHORIORETINITIS; DRUG EFFICACY; HEART DISEASE; HEART TRANSPLANTATION; HIGH RISK POPULATION; HUMAN; INFECTION PREVENTION; LETTER; LUNG DISEASE; MENINGITIS; MYOCARDIAL DISEASE; NONHUMAN; PNEUMOCYSTIS PNEUMONIA; POSTOPERATIVE COMPLICATION; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; SEROCONVERSION; TOXOPLASMA GONDII; TOXOPLASMOSIS; TREATMENT OUTCOME;

ANTIPROTOZOAL AGENTS; CHEMOPREVENTION; HEART TRANSPLANTATION; HUMANS; TOXOPLASMOSIS; TRANSPLANTATION; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION;

EID: 0037385519     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/368209     Document Type: Letter

References (0)